September 29, 2023
Cover Story
36
10
Drug efficacy, reputation, and financial return are all on the line when it comes to fill/finish.
September 29, 2023
Peer-Reviewed Research
36
10
A survey was conducted to examine the adoption of machine learning and artificial intelligence in the bio/pharma manufacturing industry.
September 29, 2023
Development
36
10
Biologics formulation comes with a unique set of challenges, which can be overcome through innovative strategies and good partnerships.
September 29, 2023
Upstream Processing
36
10
Using a systematic approach and achieving run-to-run consistency are essential.
September 28, 2023
Downstream Processing
36
10
The innovation of affinity ligands must take stability into consideration for present and future purification applications.
September 28, 2023
Manufacturing
36
10
The steady rise in popularity of gene therapies and other biologics is the underlying reason for the growing importance of aseptic manufacturing processes in the biopharmaceutical industry.
September 28, 2023
Analytics
36
10
Glycosylation analysis can provide a deep and nuanced understanding of immune cell phenotype and function.
September 28, 2023
Regulatory Beat
36
10
The agency will be reorganizing field force and compliance functions.
September 28, 2023
From the Editor
36
10
If the Alliance for mRNA Medicines (AMM) tested the waters in June 2023 at the BIO Conference in Boston, then they engaged in a full-fledged triathlon in September, in the heat and humidity of Washington, DC.
September 28, 2023
From the CEO
36
10
It has been a long wait, but for Alzheimer’s at least, this is the beginning of renewed hope.
September 28, 2023
Ask The Expert
36
10
Maintaining compliance to compendial requirements should be straightforward, says Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates.